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ABSTRAK 
10 TAHUN KAJIAN PENYAKIT ASMA TERUK Dl UNIT 
RAWATAN RAPI, HOSPITAL UNIVERSITI SAINS MALAYSIA, 
KUBANG KERIAN, KELANT AN 
PENGENALAN 
Serangan asma teruk dan tiba-tiba adalah senario biasa di Jabatan 
Kecemasan dan menjadi punca kemasukan ke hospital dan unit rawatan 
rapi. Kajian ini mendedahkan demografi pesakit tersebut dan juga sebab 
mengapa mendapat serangan yang teruk. Amat panting kita mengenal 
pasti pesakit yang cenderung mendapat asma teruk dan mengetahui 
faktor-faktornya agar dapat memberi ~ rawatan optimum. Seterusnya 
mengurangkan kadar mobiditi dan motaliti asma 
OBJEKTIF 
Menganalisa ciri demografi pesakit asma teruk yang mendapat rawatan di 
Unit Rawatan Rapi dan menganalisa faktor-faktor keterukan asma. 
: 
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METODOLOGI 
lni adalah kajian 1 0 tahun iaitu dari tahun 1990 hingga 2000. Semua 
pesakit asma teruk yang memasuki Unit Rawatan Rapi HUSM adalah 
termasuk dalam kajian. Fokus kajian adalah ciri demografi, sejarah Ieiah, 
rawatan Ieiah, sejarah Ieiah dalam keluarga, sejarah penyakit lain, sejarah 
alahan, penyebab keterukan Ieiah, komplian, ventilasi or pemerhatian, 
komplikasi Ieiah dan lain-lain. 
KEPUTUSAN 
Terdapat 103 kes kajian. 60o/o adalah perempuan. Paling ramai yang 
menerima rawatan rapi dari kumpulan berumur 30 - 34 tahun. Purata 
umur ialah 33 tahun. 76% tidak merokok, 61 °/o hadir sendiri mendapat 
rawatan, 77.3o/o mempunyai sejarah asma dalam keluarga, dan 60o/o 
adalah mereka yang dari kronik asma Faktor penyebab utama adalah 
jangkitan kuman respiratori atas (51. So/o) 7 4. Bo/o subjek kajian mempunyai 
sejarah kemasukan wad disebabkan asma dan 36.9o/o mempunyai sejarah 
. . 
kemasukan ke ·unit rawatan rapi. 73°/o adalah tidak komptian dan 79.8o/o 
pesakit didapati tidak betul teknik inhalasi. 35o/o mendapat komplikasi 
hypokalaemia. Komplikasi lain ialah pneumonia, abnormal rentak jantung 
.. 
dan sawan. Kebanyakan pesakit bertindakbalas dengan rawatan yang 
diberikan. Hanya satu kes kematian Ieiah di ICU, selebihnya adalah 
selamat. 
iii 
KESIMPULAN 
Dari kajian ini terdapat beberapa faktor mengapa pesakit mendapat asma 
teruk. Antara faktor - faktor itu ialah pesakit pertengahan usia dan lanjut 
usia, serangan asrna yang teruk secara mengejut, mereka yang tidak 
mengambil ubat secara teratur atau teknik penggunaan ubat penyedut 
yang tidak betul, dan sejarah kemasukan wad atau unit rawatan rapi. 
Serangan jangkitan saluran pernafasan dan radang paru-paru adalah 
penyebab utama serangan asma akut yang teruk. Komplikasi asma teruk 
teruk adalah mimima. Kebanyakan pesakit kajian bertindakbalas dengan 
rawatan yang diberikan. Mereka hanya tinggal beberapa hari sahaja di 
ICU sebelum dipindahkan ke wad. Unit rawatan rapi adalah amat sesuai 
untuk pesakit asma yang teruk. 
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ABSTRACT 
A TEN- YEAR STUDY ON ACUTE SEVERE ASTHMA PATIENTS IN 
THE INTENSIVE CARE UNIT (ICU) OF HOSPITAL UNIVERSITI SAINS 
MALAYSIA, KUBANG KERIAN, KELANTAN (HUSM) 
INTRODUCTION 
Acute exacerbation of severe asthma is a common presentation to the 
Emergency Department, hospital, and Intensive Care Unit admission. 
This study will review asthma patients that admitted into the intensive care 
unit of Hospital Universiti Sains Malaysia. By studying the demographic 
characteristics or patients' profile, and the precipitating factors, we can 
predict those asthmatics that will deteriorate or develop severe asthma 
symptoms. This is very important and essential to prevent the morbidity 
and mortality and to improve the outcome. 
OBJECTIVE 
The main objectives of this study are: 
1. To analyze and identify the demographic characteristics of 
asthma patients that required admission into Intensive Care 
Unit. 
2. ·To identify the common predisposing factors for severe 
asthma that required intensive care management 
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3. To identify the risk factors for severe asthma that admitted 
for mechanical ventilatory support. 
METHODOLOGY 
This is a 10-year observational study from 1999 to a 2000. All asthma 
cases that were admitted into Hospital University Science Malaysia 
Intensive Unit Care were included in the study. Variables on study were 
demographic characteristics, past medical history, allergic history, 
medications, and severity of illness, precipitating factors, compliance, 
complications, duration of stay, ventilation or observation and others. 
RESULTS 
There were 103 asthma cases in this study. Predominate by female 
patients (60.2o/o). Age group between 30 to 34 years old had a highest 
ICU admission. Mean age was 33 years old. 76o/o of the subjects were 
non-smoking asthma patients. 61.2°/o of the subjects were self-referred, 
. 
77.3o/o had a positive family history of asthma, and 58.1o/o had moderate 
severity of chronic asthma. Precipitating factors were upper respiratory 
tract infection (51.5o/o) and .P~eumonia (28.2o/o). 74.8o/o of subjects had 
previous history of hospital admission and 36. 9o/o had previous history of 
ICU admission. 73o/o had a poor compliance to medication, and 79.8o/o had 
improper technique of using the inhaler. 35°/o of the subjects had 
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hypokalaemia and 16.5o/o had a hypoxic fit. Other complications were 
pneumonia, arrythmias, and pneumothorax. 85°/o of subjects stayed less 
than 4 days in ICU. Majority of subjects responded to standard asthma 
therapy. 
CONCLUSION 
The great challenge in managing acute asthma patients in ED is to 
prevent the recurrence of asthma attack, to decide whether the required 
admission or not, and to prevent mortality. Our data showed middle and 
old asthma patients, sudden onset of severe asthma, severe chronic 
asthma, poor compliance, poor inhaler technique, history of hospital 
admission and ICU admission were important risk factors for the 
develoment of acute severe asthma. Upper respiratory infections and 
pneumonia were common precipitating factors of acute severe asthma. 
Regarding the risk for ventilation we noted it has a significant correlation 
or association with age, severity of chronic asthma, history of 
hospitalization, and ICU admission. Number of ventilated patients was 
high in middle age group, severe chronic asthma, those with a history of 
hospitalization and ICU admission, and also in those poor compliance 
patients and those who can't perform the technique of inhalation properly. 
Majority of the patients that admitted into ICU responded to standard 
therapy. The complications were minimal. These patients usually recover 
very fast and majorities of them stayed just for a few days in ICU. 
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CHAPTER 1: INTRODUCTION 
Asthma is derived from a Greek word, which means laborious 
breathing and panting. It is defined as a partial obstruction to airflow in the 
intra-thoracic airways that varies in severity over a short period of time, 
either spontaneously or as a result of treatrnent. 
During the last two decades, the prevalence of asthma, asthma 
morbidity and mortality have increased by 33o/o in the last ten years. In the 
United States, the prevalence rate of asthma had increased from 3°/o in 
1980 to 6o/o in 1994 (Thomas & Casale, 2000). Globally, The World Health 
Organization estimates that between 1 00 and 150 milt ion people suffer 
from asthma. Deaths from this disease have also reached 180,000 
annually (Dzulkifli, 2000). In our country, it is about 8-10°/o of our 
population or about 2 million Malaysian citizens are asthmatic in which 8o/o 
are an adult asthmatic and about 20o/o are childhood asthmatic (Loh Foon 
Fang, 1995). Asthma death in Malaysia was about 16.8 per million 
populations. This is double from developed countries, which are about 6 -
7 asthma deaths per million populations (Jeyaindran S, 1993} 
In Hospital Universiti Sains Malaysia (HUSM), acute exacerbation 
of asthma is a common presentation to the Emergency Department (ED). 
There was an about 8- 10 asthma cases per day. This comprised 0.1o/o of 
the ED attendances per day. Asthma is also a common disease that 
required hospitalization or Intensive Care Unit management. For example; 
in 1999 there was 340 asthma patients admitted into the medical ward. 
Majority of them admitted via ED. They presented with a various degree of 
severity, from mild symptoms to life threatening condition. Those 
presented with a severe asthma will be managed either in the ward or in 
the intensive care unit. Basically the criteria for admission into the H USM 
are based on clinical and failure of initial therapy in ED. We found out 
there was no criteria or protocol of asthma management, criteria for 
admission and how these patients were observed after therapy in HUSM. 
The initial presentation of the severity of asthma is not the only 
factor that determines whether the patients required admission or not. 
They may be deteriorated later. It is clear that patients who present with 
severe dyspnea have severe bronchospasm; however, those without 
severe shortness of breath may also have severe obstruction. Therefore 
Emergency Department has an important role to identify those asthmatics 
whom susceptible to develop severe or life threatening asthma, so that 
prompt and aggressive asthma management can be started early. 
Subsequently patients will be referred for observation or early follow up. 
Recognition and appropriate management of severe acute asthma is 
essential, not only to prevent the morbidity and mortality but also to 
improve the outcome in the future. 
Despite an increased understanding of the underlying 
pathophysiology and the improvement in the treatment of asthma, the 
morbidity and mortality are still high every year. Implicated reasons for this 
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enigma include genetic predisposition, physical environment, social 
environment, patient habits, the medical care that the patients receive, 
and the care that the patients deliver to themselves (Zorc & Joseph J. 
2000). Other specific risk factors for severe asthmatic attacks are low 
economic status, previous history of hospitalization and mechanical 
ventilation, history of respiratory arrest, frequent emergency visit, non-
compliance with therapy and sub-optimal therapy due to physician under-
prescribing or patient underutilization of appropriate medications (Thomas 
& Casale, 2000). Furthermore, the clinical approach to treating patients 
with severe, life threatening exacerbations of asthma remains 
controversial (Spevetz AS et al, 1992). The purpose of this study was to 
explore these factors and their association with severe symptoms. 
This study will review asthma patients that admitted into the 
intensive care unit of Hospital Universiti Sains Malaysia. By studying the 
demographic characteristics or patients' profile, and the precipitating 
factors, we can predict those asthmatics that will deteriorate or develop 
severe asthma symptoms. We also hope the findings of this study will help 
the medical officers or ED residents for a better managemer.tt of asthma 
patients. Eventually, this can reduce the number of admissions into the 
emergency department, hospital, or Intensive Care Unit. It is not only can 
.. 
reduce the morbidity and mortality but ultimately it can improve patient's 
quality of life. 
3 
The main objectives of this study are: 
1. To analyze and identify the demographic characteristics of asthma 
patients that required admission into Intensive Care Unit. 
2. To identify the common predisposing factors for severe asthma that 
required intensive care management 
3. To identify the risk factors for severe asthma that admitted for mechanical 
ventilatory support. 
We hope this study will help the medical practitioners in making 
decision of which asthma patients required more attention and observation 
· and also to decide whether to discharge the patient, to continue treatment, 
or to admit to the hospital. 
4 
CHAPTER 2 : LITERATURE REVIEW 
2.1 Definition 
Asthma is defined as a condition of airway hypersensitivity and 
reversible airway obstruction that results in intermittent symptoms of 
wheezing, dyspnea and cough. However, asthma is more than simple 
reversible airway obstructions. 
Based on current knowledge, a working definition of asthma is a 
chronic inflammatory disorder of the airways in which many cells and 
cellular elements play role in particular, mast cells, eosinophils, T-
lymphocytes, macrophages, neutrophils, and epithelial cells. In 
susceptible individuals, this inflammation causes recurrent episodes of 
wheezing, breathlessness, chest tightness, and coughing, particularly at 
night or in the early morning. These epi~odes are usually associated with 
widespread but variable airflow obstruction that is often reversible either 
spontaneously or with treatment. The inflammation also causes an 
associated increase in the existing bronchial hyper-responsiveness to a 
variety of stimuli (NHLBI/WHO Workshop report. 1995). -The airway 
narrowing usually reversible but in some patients with chronic asthma the 
inflammation may lead to irreversible airways obstruction (Roche WR et 
al. 1989) 
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2.2 Genetics and asthma 
The recent completion of the human genome project has 
increased the likelihood that the genetic contribution to development of 
asthma will be elucidated. At present. it does not appear that a single 
gene or single set of genes is likely to explain the pathogenesis of asthma. 
Current evidence suggests that the asthma phenotype involve the 
interaction of multiple sets of genes each contributing a small percentage 
to the phenotype. Characterisation of the genes contributing to the 
pathogenesis of asthma may identify subsets of asthma in which different 
combinations of "asthma" genes contribute to different asthma phenotypes 
(NHLBIIWHO Workshop report. 1995). Current study showed lnterleukin 
(IL)-3 and granulocyte macrophage colony-stimulating factor (GM-CSF) 
may influence the inflammatory process i.n acute severe asthmaa through 
their regulatory role on eosinophil survival, differentiation and effector 
function (Lai CK et al. 1996). 
2.3 Airway Hyperresponsiveness 
An important component of asthma underlying the instability of 
the airways is the presence of an exaggerated bronchoconstrictor 
response to a wide variety of exogenous and endogenous stimuli. Several 
mechanisms · have been proposed to explain this airway hyperrespon-
siveness. They may be classified as causing airflow limitation directly by 
6 
stimulating airway smooth muscle (e.g., methacholine and histamine) or 
indirectly by releasing pharmacologically active substances from mediator-
secreting cells, such as mast cells (exercise hyper- and hypo-osmolar 
.. stimuli) or nonmyelinated sensory neurons (sulfur dioxide, bradykinin) or a 
combination of both mechanisms. 
The clinical consequences of airway hyperresponsiveness are 
reflected in an increased variation in airway caliber both within and 
between days. No~turnal and/or early morning symptoms with a diurnal 
variation in peak expiratory flow (PEF) (which correlates well with FEV1) 
of 20 percent or more are highly characteristic of asthma. An increase of 
.. 
15 percent or more in FEV1 or PEF 1 0 to 20 minutes after inhalation of a 
short-acting beta2-agonist is accepted as diagnostic (NHLBIIWHO 
Workshop report. 1995). 
2.4 Airflow Limitation 
The recurrent episodes of airflow limitation in asthma have four 
forms. Each relates to the airway inflammatory response 
1. Acute bronchoconstriction. 
The mechanism of acute airflow limitation varies according to the 
stimulus. Allergen-induced acute bronchoconstriction results from the lgE-
7 
dependent release of mediators, including histamine, prostaglandins, and 
leukotrienes from airway mast cells that contract the smooth muscle. 
2. Airflow Limitation in Asthma 
Acute airflow limitation may also occur because airways in 
asthma are hyperresponsive to a wide variety of stimuli consequent to the 
underlying inflammation. Many stimuli can cause acute 
bronchoconstriction, such as inhalation of allergens, exercise, cold air, 
fumes, and chemicals, and strong emotional expressions like crying and 
laughing. Their mechanisms for causing bronchoconstriction use differing 
combinations of direct contraction of smooth muscle, mediator release 
from cytokine "primed" inflammatory cells, and stimulation of local and 
central neural reflexes. The acute bronchoconstriction form of airflow 
limitation is rapidly reversed with an inhaled bronchodilator agent, such as 
short-acting beta2-agonist 
3. Swelling of the airway wall. 
Airflow limitation also results from edematous swelling of the 
airway wall with or without smooth muscle contraction, or broncho-
constriction. Bronchodilators may relieve some of this component of 
airflow limitation, but it is more effectively reversed with anti-inflammatory 
drugs, especially corticosteroids. The increase in microvascular 
8 
permeability and leakage leads to the mucosal thickening and swelling of 
the airway outside the smooth muscle. This causes swelling of the airway 
wall and loss of elastic recoil pressure. Both phenomena contribute to 
airway hyperresponsiveness in asthma 
4. Chronic mucus plug formation. 
This more intractable airflow limitation, which has been little 
studied, usually takes 6 weeks or longer to resolve following the 
introduction of corticosteroid treatment. It is dominated by increased 
mucus secretion that, with exuded serum proteins and cell debris 
comprises the mucus plugs characteristically occluding the more 
peripheral airways in severe asthma (NHLBI/WHO Workshop report. 
1995). 
2.5 Airway wall remodeling. 
Airflow limitation sometimes fails to reverse with corticosteroid 
treatment. The cellular and molecular basis of this "steroid resistance" 
may be at the steroid receptor transduction level or may be associated 
with structural changes to the airway matrix accompanying longstanding 
and severe airway inflammation. 
From a clinical standpoint, airway inflammation is the most 
likely variable factor to account for varying severity of asthma and is 
therefore the element most responsive to controlling medications such as 
9 
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sodium cromoglycate, nedocromil, and corticosteroids. However, even in 
the absence of symptoms and overt airflow limitation, asthma continues to 
exist in the form of mild airway inflammation and airway hyper-
responsiveness. Death resulting from asthma is most usually 
characterized by extensive infiltration of the airways with eosinophils, mast 
cells and mononuclear cells with extensive involvement of large as well as 
small airways. Between these extremes lies the common exacerbation of 
asthma in which mucosal swelling, excess secretions, and increased 
airway responsiveness are features of the inflammatory response. 
(NHLBIIWHO Workshop report. 1995). 
2.6 Rapidity and Severity of Exacerbation 
Asthma symptoms may vary in! a variety of ways (e.g., age of 
patient, contributing mechanisms, response to medications). Patients may 
experience clinically significant decreases in pulmonary function over a 
period of minutes, hours, or days. When these alterations occur abruptly, 
patients will almost always note this change and alter their medication 
schedule or seek medical help as soon as possible. In contrast, when 
these alterations occur over a period of days or weeks, the patient's 
perception of his or her lung function is often quite different in comparison 
to objective measurements of lung function. These individuals will 
underestimate their functional impairment and may not seek appropriate 
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help or treatment early. These individuals have been termed poor 
perceivers (NHLBIIWHO Workshop report. 1995). 
2. 7 Factors causing acute exacerbation of asthma 
1. Allergens. 
Allergen exposure is a common precipitant of asthmatic 
symptoms in both children and adults. Allergic asthma involves first, the 
process of sensitization {lgE antibody formation in a genetically 
predisposed individual) and second, subsequent exposure with the 
generation of the allergic response in the lower airway. The demonstration 
that allergen exposure can produce inflammation in the lower airway has 
markedly influenced the treatment of asthma .. 
The formation of antigen-specific lgE antibody to aeroallergens 
does not usually occur until 2 to 3 years of life. It begins to increase in 
prevalence during later childhood and adolescence, and peaks in the 
second decade of life. Once established in genetically predisposed 
individuals, however, lgE-mediated reactions are a major contributor to 
both chronic airway inflammation and acute asthmatic symptoms. Long-
term, low-level exposure to indoor allergens, and dust mite and cat 
proteins in particular, may play a major role in asthma pathogenesis and 
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contribute to chronic and recurrent symptoms (Duff AL & Platts-Mills T AE. 
1992). 
The ideal treatment of allergen-induced asthma involves strict 
avoidance of the allergen. If this is not possible, premedication prior to 
allergen exposure is advisable. Administration of cromolyn sodium, 
nedocromil sodium, or a beta-agonist (eg, albuterol) 5 to 10 minutes prior 
to exposure significantly attenuates the immediate response; of these 
agents, only cromolyn and nedocromil have been shown to block the late 
response as well (Cockcroft DW & Murdock KY. 1987). 
2. Virus Infections. 
Viral respiratory infections are major causes of wheezing in-
patients of all ages. For infants, respiratory syncytial virus infectioQs 
frequently lead to wheezing. The increa~ed risk in boys appears to relate 
to a tendency for smaller lung capacity in these children. As these infants 
grow older, the majorities have fewer episodes of wheezing, and the 
eventual development of asthma is infrequent. The diminished frequency 
of wheezing with respiratory infections with increasing age relates to the 
development of immunity to the infecting virus and growth in lung function. 
(NHLBIIWHO Workshop report. 1995). 
Similarly, in-patients with established asthma; viral respiratory 
infections are major causes of a wheezing exacerbation. Recent evidence 
by Johnston (Johnston SL et al. 1995) and Nicholson (Nicholson KG et al. 
12 
1996) has shown viruses as the cause of wheezing in nearly 80o/o of 
asthma exacerbations, with rhinovirus the predominant virus detected. It is 
noteworthy that the susceptibility to wheezing with rhinovirus is seen in 
asthmatic patients of all ages. If the attacks of asthma or wheezing 
illnesses related to viral infections occurred in both adults and infants, it 
can be severe and lead to hospitalization. 
Although the mechanisms by which viral respiratory infections 
lead to increased asthma frequency of attack have not been fully 
established, several important possibilities exist, including enhancement of 
underlying allergic inflammation. There is an evidence that rhinovirus 
infections promote the development of the late allergic reaction, enhance 
eosinophil recruitment to the airway following antigen exposure, and 
cause eosinophilic infiltration of the airway. There is also evidence from in 
vitro experiments that respiratory viruse~ can stimulate the generation of 
proinflammatory cytokines including IL-1 beta, tumor necrosis factor alpha, 
and IL-11. These observations suggest that respiratory viruses enhance 
existing allergic inflammation by promoting the production of inflammatory 
mediators and up-regulating existing airway inflammation (NHLBIIWHO 
Workshop report. 1995). 
3. Air Pollution 
A number of researchers believed that air pollution causing 
the increment of asthma prevalence in general. Jonathan M. Samet 
13 
from Baltimore, Maryland that air pollution could exacerbate asthma. 
Some intriguing information about diesel exhaust particles and other 
particulate matter, and the development of allergy and asthma, 
suggest there may be some interactions that are worthy of further 
investigation (Samet JM. 2000). 
4. Impact of Environmental Tobacco Smoke Exposure 
There has been particular interest in recent years in the 
health effects of environmental tobacco smoke, including the potential 
impact of this problem on higher asthma prevalence rates. Mannino 
reported that the greatest risk factor for asthma related to 
environmental tobacco smoke occurs with postnatal or pre- and 
postnatal exposure. Postnatal exposure !was associated not only with 
an increased risk for the development of asthma but also with 
increased respiratory symptoms, increased wheezing, decreased lung 
function, and increased asthma severity (Mannino OM. 2000). 
2.8 Risk factors severe asthma 
Episodes of fatal and near fatal asthma, although not high in 
number considering the prevalence of the condition, remain all too 
common and are increasing. Ongoing studies try to describe the reasons 
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for this trend and improved understanding of the clinical circumstances 
underlying and leading to fatal or near fatal episodes of asthma. The hope 
is that recognizing risk factors for severe asthma and designing 
appropriate interventions will lead to fewer asthma morbidity and mortality 
in the future. 
There are multiple risk factors for fatal and near fatal asthma, 
including genetic predisposition, physical environment, social 
environment, patient habits, the medical care patients receive, and the 
care patients deliver to themselves. Specific risk factors that have been 
identified include a slightly higher death rate for females, low economic 
status, previous hospitalization, emergency department visits, respiratory 
arrest, or life threatening disease. Others studies have suggested 
additional risk factors, including psychosocial problems and 
noncompliance with therapy; sub optimal therapy either due to physician 
under prescribing or patient under utilization of appropriate medications; 
substance abuse; and in some cases, environmental exposure 
(Hannaway & Paul J. 2000}. Recognition and appropriate intervention can 
modify some of these risks factors. 
Investigators have become interested in whether there is 
relationship between .. patient perceptions of symptoms and dyspnea and 
life threatening asthma. In a study by Schwartzein RM , some patients feel 
dyspnea with forced expiratory volume in 1-second (FEV1) values of 90o/o, · 
whereas others are not dyspneic even when their FEV1 values are 60°/o 
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(Schwartzein RM. 2000). A 1993 study in the British Medical Journal, for 
example, found that 60°/o of subjects did not recognize the severity of their 
air flow obstruction measured by peak flow meter (Kendrick AH & Higgs 
CM. 1993) 
Not all the dyspnea is the same; different perceptions may be 
based on different physiologic parameters. Some patients who complain 
. of air hunger may have poor gas exchange and hypoxia. Others who 
complain of having a hard time breathing or requiring an increased effort 
may have an increase in restrictive loads. Patients who complain of not 
being able to have or take deep breath may have hyperinflation. Those 
subjects complaining primarily of chest tightness might have a component 
of afferent nerve stimulation in the respiratory tree. Schwartzsein noted 
chest tightness might be a better early warning sign of potentially fatal 
event than other symptoms (Schwartzeir;1 RM. 2000}. Therefore, it is vital 
for the doctors to recognize all of these types of symptoms and perform 
the appropriate diagnostic tests to help recognize and manage these 
patients. Thus, patients also need to be advice that monitoring their lung 
function is important because even with some symptomatic improvement~ 
they may still be at risk for a fatal event. 
Another factor that has been associated with fatal asthma is a 
delay in patients seeking care. What is not known is whether poor 
perception of symptoms directly relates to such delays. It was noted that 
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patients with near-fatal and fatal attacks of asthma often wait 24 hours or 
more before seeking a treatment (Harver A. 2000). 
2.9 Key interventions to Prevent Arrest in managing acute 
exacerbation of severe asthma 
Severe exacerbation of asthma can lead to several forms of 
sudden death. One classification scheme categorizes asthma on the basis 
of the onset of symptoms. Signs of rapid-onset asthma develop in <2.5 
hours, signs and symptoms of slow-onset asthma develop over several 
days (Wasserflan Jet al. 1990). 
Cardiac arrest in-patients with severe asthma has been linked to: 
1. Severe bronchospasm and mucous plugging leading to asphyxia 
(Robin ED & Lewiston N. 1989): This condition causes the vast 
majority of asthma-related deaths. 
2. Cardiac arrhythmias due to hypoxia, which is the common cause of 
asthma-related arrhythmia. In addition, arrhythmias are caused by 
use of B-adrenergic agonists. (In rare instances these arrhythmias 
may be due to prolongation of the QT interval resulting from B-
adrenergic agonists (Robin Ed & me Cauley R. 1992) or toxicity 
caused by medications such as theophylline.) 
3. Auto-PEEP (positive end-expiratory pressure) occurs in some 
patients who are intubated and mechanically ventilated. Patients fail 
: 
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to expire as much air as they took in; gradual buildup of pressure 
occurs and reduces blood flow and blood pressure. Auto-PEEP is 
secondary to air trapping and "breath stacking" (breathed air 
entering and being unable to escape). 
4. Tension pneumothorax (often bilateral) 
Most asthma-related deaths occur outside the hospital. The number of 
patients with severe attacks of asthma who present to the Emergency 
Department at night is 10 times greater than the number presenting during 
the day (Brenner BE et al. 1999}. 
The major clinical action is to treat the severe asthmatic crisis 
aggressively, before deterioration to full arrest. The specific agents and the 
treatment sequence will vary according to local practice. Emergency 
treatment and ICU management will ir:tclude some combination of the 
agents and interventions discussed below. 
1. Oxygen 
Use a concentration of inspired oxygen to achieve a Pa02 of> 91 
mm Hg. High-flow oxygen by mask is sometimes necessary. In patients 
with an asthmatic crisis, the following signs indicate that the need for rapid 
tracheal intubation is imminent: 
1. Findings of obtundation 
2. Profuse diaphoresis 
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3. Intravenous Corticosteroids 
By 2000 it became a common practice in accident and emergency 
departments to begin corticosteroid therapy early (in the first 30 minutes) 
for patients with life-threatening asthma. Corticosteroids should be started 
early, but oxygen and B-agonists always have priority as the initial agents. 
Clinicians typically use 125 mg of methylprednisolone (or equivalent 
hydrocortisone 200 mg IV) as a starting dose in cases of severe asthma 
(Rowe BH. 1992). Doses can range as low as 40 mg to as high as 250 mg 
IV or its equivalent. 
4. Nebulized Anticholinergics 
Use ipratropium, an inhaled anticholinergic agent, as a moist 
nebulizing agent in combination with albuterol at a dose of 0.5 mg (Karpel 
JP et al1996). Unlike B2-agonists, which. have an immediate onset of 
action, nebulized anticholinergic agents have a delayed onset of 
approximately 20 minutes. 
5. Intravenous aminophylline 
Aminophylline, now used as secondary therapy after Bragonists 
and corticosteroids, can enhance the effects of those agents. As a 
bronchodilator aminophylline is approximately one third as potent as Br 
agonists. Clinicians use aminophylline much more frequently in children 
than in adults. Addition of this agent to high doses of B2-agonists is 
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thought to increase side effects more than it increases bronchodilation. 
This is most evident in patients already taking theophyllines. The risk-
benefit ratio may be different in patients not taking theophyllines 
(Littenberg B. 1988) 
6. Intravenous Magnesium Sulfate 
A number of authors have reported success with magnesium sulfate in 
patients refractory to inhaled adrenergic agents and corticosteroids. 
Although not consistently effective, magnesium is widely available and can 
be administered with few side effects at a dose of 2 to 3 g (Schiermeyer 
RP & Finkelstein JA. 1994) 
7. Parenteral or Subcutaneous or Intramuscular Epinephrine or 
Terbutaline 
Subcutaneous administration of epinephrine or terbutaline may 
prevent the need for artificial ventilation in cases of life-threatening 
asthma, especially in patients who do not respond to inhaled Bragonists. 
For convenience and easy recall a non-weight-based dose of 0.3 mg 
usually is given to adults. This dose of epinephrine (0.3 mg) can be 
repeated twice at 20-minute intervals to a total of 3 injections. 
The dose of terbutaline is 0.25 mg SC every 30 minutes; up to 3 doses 
may be given. At this time there is no good evidence of advantages for IV 
B-agonists over inhaled bronchodilators (Gibbs NA et al. 2000). 
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8. Ketamine 
Ketamine is a parenteral dissociative anesthetic that has been 
found to be a useful bronchodilator. Most experts think that ketamine is the 
anesthetic agent of choice for intubation of severe asthmatics. Ketamine 
potentiates catecholamines and directly induces relaxation of smooth 
muscle. It also increases bronchial secretions and can cause emergent 
reactions. The initial dose of ketamine is 0.1 to 0.2 mg/kg followed by an 
infusion of 0.5 mglkg per hour (Hemmingsen C et al. 1994) 
2.10 Criteria for Admission to Intensive Care Unit 
Intensive care, generally in an intensive care unit with 
consultation of an · asthma specialist or a critical care specialist 
experienced in treating asthma, is indicated if the patient has any of the 
following: 
~ A lack of response to initial therapy in the emergency department 
and/or rapidly worsening asthma 
Presence of confusion, drowsiness. other signs of impending 
respiratory arrest (diaphoresis with recumbency, staring facies, 
bradypnea), or loss of Consciousness 
• Impending respiratory arrest: hypoxemia despite supplemental 
oxygen (P02 less than 60 mm Hg and/or PC02 greater than 
45 mm Hg. 
} 
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• Intubation may be needed if there is continued deterioration in 
clinical features despite optimal therapy, if the patient is exhausted, 
and/or if the PC02 is increasing. 
{Working Party of the Malaysian Thoracic Society. 1996) 
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CHAPTER3:METHODOLOGY 
3.1 Type of study 
This study was a cross-sectional observation study from 1990 
to 2000. A detailed analysis of all medical reports of patients with acute 
asthma admitted to multidisciplinary Intensive Care Unit of Hospital 
University Science Malaysia were included in the study. 
3.2 Inclusion criteria 
All asthma patients that required intensive care admission were 
included in this study. Life threatening asthma in this study was defined as 
severe attacks of asthma poorly responsive to adrenergic agents, and 
associated with signs and symptoms of impending respiratory_ failure, any 
history of drowsiness as a result of asthma, loss of consciousness, 
respiratory arrest, mechanical ventilation, or admission to the ICU for 
asthma treatment (The British guidelines on asthma management 1995 
review and position statement, 1997) 
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